Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Torsin family 4 member A (TOR4A) is a human protein encoded by the TOR4A gene located on chromosome 9. It is part of the AAA+ (ATPases Associated with diverse cellular Activities) protein superfamily and is predicted to have ATP binding and ATP hydrolysis activities[9][10][1]. TOR4A is primarily localized in the cytoplasm, endomembrane system, endoplasmic reticulum lumen, and nuclear envelope[1][5]. Its precise biological function in humans is not well defined, but as a member of the torsin family, it may play a role in intracellular trafficking, membrane dynamics, or cellular stress responses—a general property of torsin/AAA+ proteins. There is currently no evidence that TOR4A is a therapeutic target, is implicated in major disease roles, or interacts with known drugs[9][10][6]. Essential context and curation details: - The canonical name is "Torsin family 4 member A" (not "torsin-4A" or "C9orf167"); the most widely accepted abbreviation is TOR4A[9][10]. - Aliases include Torsin-4A, C9orf167, FLJ20245, and torsin family protein C9orf167[9][10]. - Protein family: It belongs to the AAA+ ATPase family and contains P-loop nucleoside triphosphate hydrolase domains[1][6]. - Function & localization: The protein binds and hydrolyzes ATP, with localization to the endoplasmic reticulum and nuclear envelope, similar to other torsin proteins[1][5]. - Disease relevance: No direct implication in major disease pathways, no well-established disease roles, and not a recognized biomarker or therapeutic target as per current literature and databases[9][10][6]. - Interactions/drugs/mechanism/safety: No documented interacting drugs, mechanisms of drug action, or specific safety concerns; these sections remain null or unknown based on current data. Limitations: There are limited functional and clinical data on TOR4A in the public domain. As of this search, most annotations are based on homology, predicted structure, and broad protein family classification[10][9][1][6]. No information supports TOR4A as a regulatory receptor, enzyme, or direct therapeutic target. References used for curation: Information has been synthesized from UniProt, NCBI Gene, EMBL-EBI InterPro, Alliance Genome Resources, and The Human Protein Atlas[10][9][6][1][5][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Torsin family 4 member A (TOR4A).